In the EU, the reduction in life expectancy due to air pollution was 7.5 months in 2010, and legislation already in place to improve air quality aims to reduce…
Based on this data, large hospitals, hospital networks, and diagnostic centers can get an overview of how many devices are being used. They can then deploy…
Until now, the plant only generated low-pressure steam from the waste heat. The steam is used in various processes and, to a limited extent, for power…
Cornel Klein, a Siemens software engineer, steers a compact yellow van through a city. After a left turn, he stops at a traffic light before proceeding…
Spasticity and related complications are relatively common after stroke, leading to poorer joint range of motion, greater pain and less sensitivity in the arm…
Yeast is being used by mankind for longer time than any other microorganism. Bread, beer, wine – all of these could not be produced without Saccharomyces…
Researchers from the Paul Scherrer Institute (PSI) have developed a coating technique in the laboratory that could raise the efficiency of fuel cells. Fuel…
Processes for cutting stacked sheets of paper are incredibly advanced in technological terms. Having said that, quality defects are still occurring when…
Humans carry a multitude of viruses and bacteria in their gut, on their skin and in other organs. Often, these are involved in important bodily functions….
Deforestation in the Brazilian Amazon has declined recently. While in 2004, trees were still being felled on more than 27,000 square kilometers of land, the…
The new technology provides a method for production of a standardized ?off-the-shelf? composition comprising human MSC with reliable efficacy, built on a precisely controlled GMP compliant ex vivo expansion manufacturing process.
The present invention relates to an antibody that exhibit a high affinity and mono-specificity for the A1/B-domains of human CEACAM1. Thus, it is suitable to detect the membrane anchored, the cleaved soluble CEACAM1 and most of its derivatives. It is of use in several research applications, including ELISA, WB, IP, IHC, fluorescence microscopy and flow cytometry. In addition, the monoclonal antibody (mAB) is suitable for use as a diagnostic tool for the detection of inflammatory disorders (e.g. sepsis, multiple sclerosis) as well as for solid tumors, and applies for therapy monitoring of the latter.
Cancer patient data have been generated that support the diagnostic potential. A German patent application has been filed. On behalf of the University of Duisburg-Essen, PROvendis offers access to the antibody for commercial use.
Studies of a wide variety of extensional processes, ranging from plate thinning to magma intrusion, have helped scientists understand how continents are broken…
Observations using NASA's Chandra X-ray Observatory revealed that the unusually large magnetosphere around an O-type star called NGC 1624-2 contains a raging…
The proof of concept study represents a promising route to mitigate the buildup of carbon dioxide, a major greenhouse gas in the environment, said researchers….
Feedback
